Glycine (Baxter Healthcare Corporation)


Welcome to the PulseAid listing for the Glycine drug offered from Baxter Healthcare Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Baxter Healthcare Corporation
NON-PROPRIETARY NAME: Glycine
SUBSTANCE NAME: GLYCINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: IRRIGATION
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1980-05-30
END MARKETING DATE: 0000-00-00


Glycine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGlycine from Baxter Healthcare Corporation
LABELER NAME: Baxter Healthcare Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 1.5(g/100mL)
START MARKETING DATE: 1980-05-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0338-0289_d08782ed-bcdc-49e2-bce3-0e757c4692b3
PRODUCT NDC: 0338-0289
APPLICATION NUMBER: NDA017865

Other GLYCINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
B. Braun Medical Inc.Glycine
Baxter Healthcare CorporationGlycine
Hospira, Inc.Glycine